Safety and Toxicology of PRONOVA UP Sodium alginates

Sodium Alginates are manufactured in Sandvika, Norway in accordance with GMP guidelines; ICH Q7 and ISO standards; ISO 9001:2000, ISO 13485:2003 and ISO 22442:2007.
 
Ultrapure - UP- implies that the products contain low levels of residual endotoxin. The current specification is <100 EU/g. PRONOVA sodium alginate products are ideal for a wide variety of pharmaceutical, biomedical, biotechnology and tissue engineering applications.

Click here for more information on the Drug Master File submitted to the US FDA